BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8767850)

  • 1. [Biotransformation of the lipoxygenase inhibitor 2-hydroxy-5-methyl-laurophenone-oxime (FLM 5011)].
    Langner A; Rentsch C; Nerlich C; Rittner I; Kühn H; Schewe T; Franke P
    Pharmazie; 1996 Jun; 51(6):403-9. PubMed ID: 8767850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The biotransformation of the immunostimulant 3-(2-mercaptoethyl)quinazoline-2,4(1H,3H)-dione (AWD 100-041)].
    Langner A; Kempa S; Nerlich C; Franke P; Pfeifer S
    Pharmazie; 1994; 49(2-3):169-75. PubMed ID: 8171080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation and toxicity of the lipoxygenase inhibitor 2-hydroxy-5-methyllaurophenone oxime (FLM 5011) on Hep G2 cells.
    Mühlenfeld K; Langner A
    Arch Pharm (Weinheim); 1998; 331(7-8):259-61. PubMed ID: 9747183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biotransformation of the anticonvulsant 4-p-chlorophenylpyrrol-3-morpholino-2-carboxylic acid methyl ester (AWD 140-076)].
    Langner A; Rätzer J; Rickert H; Nerlich C; Franke P
    Pharmazie; 1993 Nov; 48(11):849-53. PubMed ID: 8295913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
    Boberg M; Angerbauer R; Kanhai WK; Karl W; Kern A; Radtke M; Steinke W
    Drug Metab Dispos; 1998 Jul; 26(7):640-52. PubMed ID: 9660846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of metabolites in urine and feces from rats dosed with the heterocyclic amine, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C).
    Frederiksen H; Frandsen H
    Drug Metab Dispos; 2004 Jun; 32(6):661-5. PubMed ID: 15155558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo metabolism of desogestrel in several species.
    Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM
    Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiinflammatory effect of a lipoxygenase inhibitor (FLM 5011) in severe active myocarditis.
    Geissler W; Förster A; Schewe T; Rapoport SM; Slapke J; Meyer R; Romaniuk P; Reisinger I
    Biomed Biochim Acta; 1988; 47(10-11):S311-4. PubMed ID: 3150273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: identification of new biotransformation pathways in the metabolism of 3'-hydroxy-delta-9-tetrahydrocannabinol by the mouse.
    Harvey DJ
    Xenobiotica; 1989 Dec; 19(12):1437-47. PubMed ID: 2559552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976). Identification of a novel five-carbon cleavage metabolite in rats.
    Sinz MW; Black AE; Bjorge SM; Holmes A; Trivedi BK; Woolf TF
    Drug Metab Dispos; 1997 Jan; 25(1):123-30. PubMed ID: 9010639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative cleavage of the pentyl side-chain of cannabinoids. Identification of new biotransformation pathways in the metabolism of 4'-hydroxy-delta-9-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Drug Metab Dispos; 1990; 18(3):350-5. PubMed ID: 1974198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amine, 2-amino-9H-pyrido[2,3-b]indole (AalphaC).
    Frederiksen H; Frandsen H
    Food Chem Toxicol; 2004 Jun; 42(6):879-85. PubMed ID: 15110096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of the absorption of the active substance 2'-hydroxy-5'-methyllaurophenoxamine (FLM 5011) with prodrugs and preparations].
    Tscheuschner C; Neubert R; Fürst W; Lücke L; Fries G
    Pharmazie; 1993 Sep; 48(9):681-4. PubMed ID: 8234402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biotransformation and excretion of Z-2-amino-5-chlorobenzophenoneamidinohydrazone].
    Borchert HH; Schieweck A; Franke P; Morgenroth U; Joram U
    Pharmazie; 1993 May; 48(5):365-70. PubMed ID: 8327565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration.
    Mathews JM; deCosta K; Thomas BF
    Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of leukotriene B4 in cultured hepatoma cells.
    Wheelan P; Murphy RC
    Arch Biochem Biophys; 1995 Aug; 321(2):381-9. PubMed ID: 7646063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.